An age-related decline in interleukin-10 may contribute to the increased expression of interleukin-6 in brain of aged mice

NeuroImmunoModulation

Volumn 9, Issue 4, 2001, Pages 183-192

  Ye, Shi Ming ^a   Johnson, Rodney W ^a  

^a UNIVERSITY OF ILLINOIS AT URBANA CHAMPAIGN   (United States)

Author keywords

Aging; Brain; Cytokines; Interleukin 10; Interleukin 6

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RECOMBINANT INTERLEUKIN 6;

AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CELL CULTURE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG DETERMINATION; GENE EXPRESSION; GLIA CELL; INCUBATION TIME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN EXPRESSION; STEADY STATE;

AGING; ANIMALS; BRAIN; BRAIN CHEMISTRY; GENE EXPRESSION REGULATION, DEVELOPMENTAL; INTERLEUKIN-10; INTERLEUKIN-6; LIPOPOLYSACCHARIDES; MICE; MICE, INBRED BALB C; NERVE TISSUE PROTEINS; NEUROGLIA; NF-KAPPA B; OLIGONUCLEOTIDE PROBES; PROMOTER REGIONS (GENETICS); RECOMBINANT PROTEINS; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0035720799     PISSN: 10217401     EISSN: None     Source Type: Journal    
DOI: 10.1159/000049025     Document Type: Article

References (35)

1. Anorexia induced by activators of the signal transducer gp 130
2. Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin-6 in the brain
3. Sickness behavior in mice deficient in interleukin-6 during turpentine abscess and influenza pneumonitis
4. Central administration of rat IL-6 induces HPA activation and fever but not sickness behavior in rats
5. Occurrence of interleukin-6 in cortical plaques of Alzheimer's disease patients may precede transformation of diffuse into neuritic plaques
6. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin-6
7. Increased interleukin-6 production by cerebral cortical tissue of adult versus young mice
8. Increased interleukin-6 expression by microglia from brain of aged mice
9. Regulation of interleukin-6 gene expression in brain of aged mice by nuclear factor κB
10. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms
11. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
12. Production of interleukin-10 by mouse glial cells in culture
13. Tumor necrosis factor alpha upregulates human microglial cell production of interleukin-10 in vitro
14. Interleukin-10 inhibits both production of cytokines and expression of cytokine receptor in microglia
15. Interleukin (IL)-10 inhibits IL-6 production in microglia by preventing activation of NF-κB
16. Increased tumor necrosis factor and interleukin-6 production in the central nervous system of interleukin-10-deficient mice
17. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples
18. Presence of interleukin-10 transcripts in human pituitary and hypothalamus
19. Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: Pathophysiological implications
20. Attenuation of astroglial reactivity by interleukin-10
21. Interleukin-10 improves outcome and alters proinflammatory cytokine expression after experimental traumatic brain injury
22. IL-10 reduces rat brain injury following focal stroke
23. Systemically (but not intrathecal-ly) administered IL-10 attenuates pathophysiologic alterations in experimental pneumococcal meningitis
24. Interleukin-10 modulates susceptibility in experimental cerebral malaria
25. Central injection of IL-10 antagonizes the behavioural effects of lipopolysaccharide in rats
26. Age-associated alterations in hippocampal and basal forebrain nuclear factor kappa B activity
27. Interleukin-10 signaling blocks inhibitor of κB kinase activity and nuclear factor κB DNA binding
28. NF-kappa B: Ten years after
29. Interleukin-10
30. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13
31. Altered cytokine production in the elderly
32. Dysregulation of IL-10 production with aging: Possible linkage to the age-associated decline in DHEA and its sulfated derivative
33. Postthymic development of CD28-CD8+ T cell subset: Age-associated expansion and shift from memory to naive phenotype